GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Cyclically Adjusted PB Ratio

BioDelivery Sciences International (FRA:BD5) Cyclically Adjusted PB Ratio : (As of May. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioDelivery Sciences International Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioDelivery Sciences International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Cyclically Adjusted PB Ratio Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioDelivery Sciences International's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Cyclically Adjusted PB Ratio falls into.



BioDelivery Sciences International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioDelivery Sciences International's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2021 is calculated as:

For example, BioDelivery Sciences International's adjusted Book Value per Share data for the three months ended in Dec. 2021 was:

Adj_Book=Book Value per Share/CPI of Dec. 2021 (Change)*Current CPI (Dec. 2021)
=1.637/117.6295*117.6295
=1.637

Current CPI (Dec. 2021) = 117.6295.

BioDelivery Sciences International Quarterly Data

Book Value per Share CPI Adj_Book
201203 0.637 96.783 0.774
201206 0.752 96.819 0.914
201209 0.282 97.633 0.340
201212 1.012 96.871 1.229
201303 0.807 98.209 0.967
201306 0.540 98.518 0.645
201309 0.216 98.790 0.257
201312 -0.016 98.326 -0.019
201403 0.970 99.695 1.145
201406 0.926 100.560 1.083
201409 0.831 100.428 0.973
201412 0.855 99.070 1.015
201503 0.880 99.621 1.039
201506 0.593 100.684 0.693
201509 0.333 100.392 0.390
201512 0.552 99.792 0.651
201603 0.332 100.470 0.389
201606 0.111 101.688 0.128
201609 -0.084 101.861 -0.097
201612 -0.309 101.863 -0.357
201703 0.646 102.862 0.739
201706 0.421 103.349 0.479
201709 0.283 104.136 0.320
201712 0.134 104.011 0.152
201803 0.019 105.290 0.021
201806 0.587 106.317 0.649
201809 0.432 106.507 0.477
201812 0.369 105.998 0.409
201903 0.323 107.251 0.354
201906 0.654 108.070 0.712
201909 0.687 108.329 0.746
201912 0.653 108.420 0.708
202003 0.694 108.902 0.750
202006 0.746 108.767 0.807
202009 0.805 109.815 0.862
202012 0.878 109.897 0.940
202103 0.914 111.754 0.962
202106 0.960 114.631 0.985
202109 1.056 115.734 1.073
202112 1.637 117.630 1.637

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioDelivery Sciences International  (FRA:BD5) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioDelivery Sciences International Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines